4//SEC Filing
Gryaznov Sergei 4
Accession 0001127602-22-027093
CIK 0001878313other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:36 PM ET
Size
6.5 KB
Accession
0001127602-22-027093
Insider Transaction Report
Form 4
Gryaznov Sergei
Chief Scientific Officer
Transactions
- Exercise/Conversion
Stock Options
2022-12-07−10,000→ 40,000 totalExercise: $1.83Exp: 2031-04-15→ Common Stock (10,000 underlying) - Exercise/Conversion
Common Stock
2022-12-07$1.83/sh+10,000$18,300→ 44,511 total
Footnotes (1)
- [F1]Represents an option to purchase shares of Common Stock granted pursuant to the 2020 Equity Incentive Plan. These options vest in 36 equal monthly instalments beginning on January 1, 2021.
Documents
Issuer
MAIA Biotechnology, Inc.
CIK 0001878313
Entity typeother
Related Parties
1- filerCIK 0001913228
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 5:36 PM ET
- Size
- 6.5 KB